|
0118
Toluene;
CASRN 108-88-3
Health assessment information on a chemical substance is included in IRIS
only after a comprehensive review of chronic toxicity data by U.S. EPA
health scientists from several Program Offices and the Office of Research
and Development. The summaries presented in Sections I and II represent
a consensus reached in the review process. Background information and
explanations of the methods used to derive the values given in IRIS are
provided in the Background Documents.
STATUS OF DATA FOR Toluene
File First On-Line 01/31/1987
Oral RfD Assessment (I.A.) |
on-line |
04/01/1994
|
Inhalation RfC Assessment (I.B.) |
on-line |
08/01/1992 |
Carcinogenicity Assessment (II.) |
on-line
|
02/01/1994
|
_I.
Chronic Health Hazard Assessments for Noncarcinogenic Effects
_I.A.
Reference Dose for Chronic Oral Exposure (RfD)
Substance Name -- Toluene
CASRN -- 108-88-3
Last Revised -- 04/01/1994
The oral Reference Dose (RfD) is based on the assumption that thresholds
exist for certain toxic effects such as cellular necrosis. It is expressed
in units of mg/kg-day. In general, the RfD is an estimate (with uncertainty
spanning perhaps an order of magnitude) of a daily exposure to the human
population (including sensitive subgroups) that is likely to be without
an appreciable risk of deleterious effects during a lifetime. Please refer
to the Background Document for an elaboration of these concepts. RfDs
can also be derived for the noncarcinogenic health effects of substances
that are also carcinogens. Therefore, it is essential to refer to other
sources of information concerning the carcinogenicity of this substance.
If the U.S. EPA has evaluated this substance for potential human carcinogenicity,
a summary of that evaluation will be contained in Section II of this file.
__I.A.1.
Oral RfD Summary
Changes in liver and
kidney weights
13-Week Rat Gavage
Study
NTP, 1989
|
NOAEL: 312 mg/kg
converted to 223
mg/kg/day
LOAEL: 625 mg/kg
converted to 446
mg/kg/day
|
1000
|
1
|
2E-1
mg/kg/day
|
*Conversion Factors: Dose adjusted for gavage schedule of 5 days/week.
__I.A.2.
Principal and Supporting Studies (Oral RfD)
NTP (National Toxicology Program). 1989. Toxicology and Carcinogenesis
Studies of toluene in F344/N rats and B6C3F1 mice. Technical Report Series
No. 371. Research Triangle Park, NC.
The oral toxicity of toluene was investigated in this subchronic gavage study
in F344 rats. Groups of 10 rats/sex/group were administered toluene in corn
oil at dosage levels of 0, 312, 625, 1250, 2500, or 5000 mg/kg for 5 days/week
for 13 weeks. All animals receiving 5000 mg/kg died within the first week.
One female and 8 males in the 2500 mg/kg group died, but 2 of these were due
to gavage errors. No deaths occurred at lower doses. Several toxic effects
were noted at doses greater than or equal to 2500 mg/kg, including
prostration, hypoactivity, ataxia, piloerection, lacrimation, excessive
salivation, and body tremors. No signs of biologic significance were seen in
groups receiving less than or equal to 1250 mg/kg. The only significant
change in body weight was a decrease (p<0.05) for males in the 2500 mg/kg
group. There were no toxicologically significant changes in hematology or
urinalysis for any group of animals. Biochemical changes, including a
significant increase (p<0.05) in SGOT in 2500 males and a dose-related
increase in cholinesterase in females receiving 2500 and 5000 mg/kg, were not
considered to be biologically significant. There were several pathologic
findings and organ weight changes in the liver, kidney, brain, and urinary
bladder. In males, absolute and relative weights of both the liver and kidney
were significantly increased (p<0.05) at doses greater than or equal to 625
mg/kg. In females, absolute and relative weights of the liver, kidney, and
heart were all significantly increased at doses greater than or equal to 1250
mg/kg (p<0.01 for all comparisons except p<0.05 for absolute kidney and heart
weights at 1250 mg/kg). Histopathologic lesions in the liver consisted of
hepatocellular hypertrophy, occurring at greater than or equal to 2500 mg/kg.
Nephrosis was observed in rats that died, and damage to the tubular epithelia
of the kidney occurred in terminally sacrificed rats. Histopathologic changes
were also noted in the brain and urinary bladder. In the brain, mineralized
foci and necrosis of neuronal cells were observed in males and females at 2500
mg/kg and males at 1250 mg/kg. In the bladder, hemorrhage of the muscularis
was seen in males and females at 5000 mg/kg and males at 2500 mg/kg. The
NOAEL for this study is 312 mg/kg/day based on liver and kidney weight changes
in male rats at 625 mg/kg. The toxicologic significance of these organ weight
changes is strengthened by the occurrence of histopathologic changes in both
the liver and kidney at higher doses. Because the exposure was for 5
days/week, this dose is converted to 312 x 5/7 = 223 mg/kg/day. The LOAEL is
625 mg/kg, which is 446 mg/kg/day when converted.
NTP (1989) also conducted a 13-week gavage study in B6C3F1 mice, following the
same regimen described above. All mice receiving 5000 mg/kg died and 8/20
receiving 2500 mg/kg also died. Signs of toxicity seen in animals receiving
greater than or equal to 2500 mg/kg included subconvulsive jerking,
prostration, impaired grasping reflex, bradypnea, hypothermia, ataxia, and
hypoactivity. By week 13, the mean body weight of 2500 mg/kg males was
significantly (p<0.05) lower than controls. No other significant changes were
reported for any group, including macroscopic observation, organ weight means,
or clinical pathology parameters. The NOAEL for mice in this study was 1250
mg/kg.
The subchronic study by Wolf et al. (1956) is supportive of the NTP studies.
Groups of 10 female Wistar rats were administered gavage doses of 0, 118, 354,
or 590 mg/kg toluene dissolved in olive oil. A total of 138 doses were
administered over 193 days, resulting in average doses of approximately 0, 84,
253, or 422 mg/kg/day. Hematologic, behavioral, gross and histopathologic
examinations were conducted with no toxic effects being reported at any dose.
Therefore, the highest dose of 422 mg/kg/day is considered to be the NOAEL for
this study. However, this study is not used as the basis for the RfD because
the LOAEL of 446 mg/kg/day identified by NTP (1989) is too close to the NOAEL
identified by Wolf et al. (1956). Also, the NTP study indicated that male
rats are more sensitive to toluene and the Wolf study utilized only female
rats.
__I.A.3.
Uncertainty and Modifying Factors (Oral RfD)
UF -- An uncertainty factor of 1000 was applied to account for inter- and
intraspecies extrapolations, for subchronic-to-chronic extrapolation and for
limited reproductive and developmental toxicity data.
MF -- None
__I.A.4.
Additional Studies/Comments (Oral RfD)
Kostas and Hotchin (1981) exposed NYLAR mice pre- and post-natally to toluene
provided in the drinking water at concentrations of 0, 16, 80, or 400 ppm.
Effects were noted in all dosed groups on rotorod performance, measured at 45
to 55 days of age, but there was an inverse dose-response relationship. No
effects of toluene exposure were seen on maternal fluid consumption, offspring
mortality rate, development of eye or ear openings, or surface-righting
response. This study is not suitable for use in risk assessment because only
6 to 9 pregnancies/dose group were obtained, and because the dose-response
relationship was inverse.
In an abstract providing limited information, Nawrot and Staples (1979)
reported an increase in embryonic lethality in mice exposed to toluene from
days 6 to 15 of gestation. Pregnant CD-1 dams were administered 0.3, 0.5, or
1.0 mL/kg bw, 3 times/day (equivalent to approximately 780, 1300, or 2600
mg/kg/day). Maternal toxicity was not observed at any dose level, but toluene
was shown to be teratogenic at the high dose and embryolethal at the low dose.
These levels are higher than the NOAEL demonstrated by the NTP (1989) study.
Several subchronic and chronic inhalation studies have been performed on
toluene but are not considered to be suitable for deriving an oral RfD. These
studies are summarized nicely in the introduction to the 2-year inhalation
bioassay by NTP, 1989. The studies identify the following potential target
organs: kidney (male rat); hematologic effects (mice); central nervous system
(rats, mice, primates); developmental toxicity (rats, rabbits). It is beyond
the scope of this oral RfD summary sheet to describe each of these studies,
but the two chronic (2 year) inhalation studies are summarized briefly below.
In a 2-year inhalation study by NTP (1989), F344 rats (60/sex/group) were
exposed to 0, 600, or 1200 ppm toluene and B6C3F1 mice (60/sex/group) to 0,
120, 600, or 1200 ppm toluene for 6.5 hours/day, 5 days/week. Ten
animals/group (except male mice) were removed at 15 months for toxicologic
evaluation. At 15 months, there was an increased incidence and severity of
nonneoplastic lesions of the nasal cavity of exposed rats. Minimal
hyperplasia of the bronchial epithelium was seen in 4/10 female mice at 1200
ppm. There were no significant differences in survival among any group of
animals during the 2-year study. Mean body weights were generally similar for
all groups throughout the study. Nephropathy was seen in almost all rats with
the severity somewhat increased in exposed rats. There were also effects on
the olfactory and respiratory epithelia of exposed rats. No biologically
important lesions were seen in any groups of mice. There was no evidence of
carcinogenicity for any group of animals in this study.
A chronic inhalation study in rats performed by CIIT (1980) failed to produce
an adverse effect. Groups of 40 F344 rats/sex were exposed to 30, 100, or 300
ppm toluene for 6 hours/day, 5 days/week for 24 months. An unexposed group of
120 rats/sex served as a control. Clinical chemistry, hematology, and
urinalysis testing were conducted at 18 and 24 months. All parameters
measured at the termination of the study were normal except for a dose-related
reduction in hematocrit values in females exposed to 100 and 300 ppm toluene.
The highest dose of 300 ppm was considered to be a NOAEL.
__I.A.5.
Confidence in the Oral RfD
Study: High
Database: Medium
RfD: Medium
Confidence in the principal study is high because a sufficient number of
animals/sex were tested in each of six dose groups (including vehicle
controls) and many parameters were studied. The same protocol was tested in
both mice and rats, with rats being identified as the more sensitive species.
The database is rated medium because it is supported by a 6-month oral study.
It is not higher than medium because there is no reproductive study. Also,
the oral studies are all subchronic, with the critical study being only 13
weeks in duration. Medium confidence in the RfD follows.
__I.A.6.
EPA Documentation and Review of the Oral RfD
Source Document -- This assessment is not presented in any existing U.S. EPA
document.
Other EPA Documentation -- None
Agency Work Group Review -- 05/20/1985, 08/05/1985, 08/05/1986, 05/17/1990, 06/20/1990
Verification Date -- 06/20/1990
__I.A.7.
EPA Contacts (Oral RfD)
Please contact the IRIS Hotline for all
questions concerning this assessment or IRIS, in general, at (202)566-1676
(phone), (202)566-1749 (FAX) or hotline.iris@epa.gov
(internet address).
Back to top
_I.B.
Reference Concentration for Chronic Inhalation Exposure (RfC)
Substance Name -- Toluene
CASRN -- 108-88-3
Last Revised -- 08/01/1992
The inhalation Reference Concentration (RfC) is analogous to the oral RfD and
is likewise based on the assumption that thresholds exist for certain toxic
effects such as cellular necrosis. The inhalation RfC considers toxic effects
for both the respiratory system (portal-of-entry) and for effects peripheral
to the respiratory system (extrarespiratory effects). It is expressed in
units of mg/cu.m. In general, the RfC is an estimate (with uncertainty
spanning perhaps an order of magnitude) of a daily inhalation exposure of the
human population (including sensitive subgroups) that is likely to be without
an appreciable risk of deleterious effects during a lifetime. Inhalation RfCs
were derived according to the Interim Methods for Development of Inhalation
Reference Doses (EPA/600/8-88/066F August 1989) and subsequently, according to
Methods for Derivation of Inhalation Reference Concentrations and Application
of Inhalation Dosimetry (EPA/600/8-90/066F October 1994). RfCs can also be
derived for the noncarcinogenic health effects of substances that are
carcinogens. Therefore, it is essential to refer to other sources of
information concerning the carcinogenicity of this substance. If the U.S. EPA
has evaluated this substance for potential human carcinogenicity, a summary of
that evaluation will be contained in Section II of this file.
__I.B.1.
Inhalation RfC Summary
Neurological effects Occupational
Study
Foo et al., 1990 |
NOAEL: None
LOAEL: 332 mg/cu.m (88 ppm)
LOAEL(ADJ): 119 mg/cu.m
LOAEL(HEC): 119 mg/cu.m
|
300
|
1
|
4E-1
mg/cu.m
|
Degeneration of
nasal epithelium
2-Year Rat Chronic
Inhalation Study
NTP, 1990
|
NOAEL: None
LOAEL: 2261 mg/cu.m (600 ppm)
LOAEL(ADJ): 437 mg/cu.m
LOAEL(HEC): 79 mg/cu.m
|
*Conversion Factors: MW = 92.15.
Foo et al., 1990: Assuming 25 C and 760 mmHg, LOAEL (mg/cu.m) = 88 ppm x
92.15/24.45 = 332 mg/cu.m. This is an extrarespiratory effect of a soluble
vapor. The LOAEL is based on an 8-hour TWA occupational exposure. MVho = 10
cu.m/day, MVh = 20 cu.m/day. LOAEL(HEC) = LOAEL(ADJ) = 332 x MVho/MVh x 5
days/7 days = 119 mg/cu.m.
NTP, 1990: Assuming 25 C and 760 mmHg, LOAEL (mg/cu.m) = 600 ppm x
92.15/24.45 = 2261 mg/cu.m. LOAEL(ADJ) = LOAEL (mg/cu.m) x 6.5 hours/24 hours
x 5 days/7 days = 437 mg/cu.m. The LOAEL(HEC) was calculated for a
gas:respiratory effect in the extrathoracic region. MVa = 0.24 cu.m/day, MVh
= 20 cu.m/day, Sa (ET) = 11.6 sq.cm, Sh (ET) = 177 sq.cm. RGDR = (MVa/Sa) /
(MVh/Sh) = 0.18. LOAEL(HEC) = 437 x RGDR = 79 mg/cu.m.
__I.B.2.
Principal and Supporting Studies (Inhalation RfC)
Foo, S., J. Jeyaratnam and D. Koh. 1990. Chronic neurobehavioral effects of
toluene. Br. J. Ind. Med. 47(7): 480-484.
NTP (National Toxicology Program). 1990. Toxicology and carcinogenesis
studies of toluene in F344/N rats and B6C3F1 mice (inhalation studies). NTP-
TR-371. 253 p.
In humans, toluene is a known respiratory irritant with central nervous
system (CNS) effects. Because available studies could not provide
subthreshold (NOAEL) concentrations for either of these effects, the LOAELs
for both effects need to be considered in developing the RfC. Consequently,
the study of Foo et al. (1990) was used for the CNS effects, and that of the
National Toxicology Program (NTP, 1990) for the irritant effects. Because the
CNS effect was judged to be a more severe and relevant endpoint, the LOAEL for
this effect was used for deriving the RfC. Further, this effect is supported
by a number of other occupational studies that show effects around 100 ppm.
Foo et al. (1990) conducted a cross-sectional study involving 30 exposed
female workers employed at an electronic assembly plant where toluene was
emitted from glue. Toluene levels reported in the study were from personal
sample monitoring and reported as an 8-hour TWA, although the number of
samples taken and the actual sampling period were not given. No historical
exposure values were given. Co-exposure to other solvents was not addressed
in the study. The exposed and control cohorts were matched for age,
ethnicity, and use of medications. Members of these cohorts did not use
alcohol and were nonsmokers. Medical histories were taken to eliminate any
histories of central or peripheral nervous system disorders. The average
number of years (+/- SD) worked by the exposed population was 5.7 +/- 3.2 and
by the controls was 2.5 +/- 2.7. Exposed workers breathed toluene air levels
of 88 ppm (332 mg/cu.m) as a TWA and control workers 13 ppm (49 mg/cu.m)
(TWA); both of which are averages of the individual personal samples. A
battery of eight neurobehavioral tests were administered to all exposed and
control workers. The tests were performed midweek, before the workers reported
to their stations for the day. Group means revealed statistically significant
differences in 6/8 tests; all tests showed that the exposed workers performed
poorly compared with the control cohort. When individual test results were
linearly regressed against personal exposure concentrations, poor
concentration-response relationships resulted for the six tests, with
correlation coefficients ranging from 0.44 to 0.30. Irritation effects were
not evaluated in this study, and no clinical signs or symptoms were reported.
The paucity of exposure information, coupled with the small size of the
cohort, limits the interpretation of this study, although the results were
essentially confirmed in a clinical study in which the toluene concentrations
were carefully controlled (Echeverria et al., 1989) at levels bracketing 88
ppm. Although the data in Echeverria et al. (1989) were generated from short-
term exposures (3-7 hours over a period of 142 days), the results may be
considered relevant to longer-term exposures as several studies indicate the
absence of a duration-response relationship in toluene-induced symptomatology.
Fornazzari et al. (1983) noted the absence of a duration-effect relationship
among toluene abusers when they were segregated into neurologically impaired
vs. unimpaired (p = 0.65). The human studies of Iregren (1982), Cherry et al.
(1985), Baelum et al. (1985), and the principal study of Foo et al. (1990) all
report this lack of a duration-response relationship and confirm the
occurrence of CNS effects. Foo et al. (1990) indicate a LOAEL of 88 ppm
toluene (332 mg/cu.m) for neurobehavioral changes from chronic exposure to
toluene.
In a 2-year bioassay, Fischer 344 rats (60/sex/group) were exposed to 0,
600, or 1200 ppm (0, 2261, or 4523 mg/cu.m, respectively) toluene vapors, 6.5
hours/day, 5 days/week (duration-adjusted to 0, 437, and 875 mg/cu.m,
respectively) for 103 weeks (NTP, 1990). To generate toluene vapor, the
liquid material was heated, and the vapor diluted with nitrogen and mixed with
the chamber ventilation air. An interim sacrifice was carried out at 15
months on control and 1200-ppm groups (10/sex/group) to conduct hematology and
histopathology of the brain, liver, and kidney. Body weights were measured
throughout the study. Gross necropsy and micropathology examinations were
performed at the end of the study on all major organs including the nasal
passage tissues (three sections), lungs, and mainstem bronchi. Mean body
weights in both exposed groups were not different from controls for either
sex. No exposure-related clinical signs were reported, and survival rate was
similar for all groups. At the interim sacrifice, there was a mild-to-
moderate degeneration in the olfactory and respiratory epithelium of the nasal
cavity in 39/40 rats of the 600- and 1200-ppm groups compared with 7/20
controls. At the end of 2 years, there was a significant (p<0.05) increase in
the incidence of erosion of the olfactory epithelium (males: 0/50, 3/50, and
8/49; females: 2/49, 11/50, and 10/50; at 0, 600, and 1200 ppm, respectively)
and of degeneration of the respiratory epithelium (males: 15/50, 37/50, and
31/49; females: 29/49, 45/50, and 39/50; at 0, 600, and 1200 ppm,
respectively) in the exposed animals. The females exposed to 600 and 1200 ppm
also exhibited a significant increase in inflammation of the nasal mucosa
(27/49, 42/50, and 41/50 at 0, 600, and 1200 ppm, respectively) and
respiratory metaplasia of the olfactory epithelium (0/49, 2/50, and 6/50 at 0,
600, and 1200 ppm, respectively). A LOAEL of 600 ppm toluene was determined
for the concentration-dependent increase in erosion of the olfactory
epithelium in male rats and the degeneration of the respiratory epithelium in
both sexes. No NOAEL could be derived from this study.
__I.B.3.
Uncertainty and Modifying Factors (Inhalation RfC)
UF -- An uncertainty factor of 10 is used to account for intraspecies
variability and another factor of 10 for the use of a LOAEL. An additional
factor of 3 is applied for database deficiencies, including the lack of data
and well-characterized laboratory animal exposures evaluating neurotoxicity
and respiratory irritation.
MF -- None
__I.B.4.
Additional Studies/Comments (Inhalation RfC)
Toluene-induced neurotoxicity has been documented in humans over a broad
spectrum of severity that correlates well with concentration. Numerous case
studies on chronic toluene abusers [repeatedly exposed to greater than 30,000
ppm (113,000 mg/cu.m)] have demonstrated functional deficits of the CNS
accompanied by abnormal morphology of cerebellar and cortical areas of the
brain. Under acute exposure conditions [short exposures to greater than
10,000 ppm (37,690 mg/cu.m)], toluene produces CNS narcosis [American
Conference of Governmental Industrial Hygienists (ACGIH), 1991]. Lower
concentrations, i.e., 800-400 ppm (3015-1508 mg/cu.m), have been associated
with worker complaints of CNS-related effects (ACGIH, 1991). Clinical studies
using controlled exposure to toluene have demonstrated concentration-related
occurrence of complaints such as drowsiness, ataxia, visual impairment, and
headache. A number of occupational studies indicate that these same effects
are present in exposed worker populations at concentrations lower than 400 ppm
(1508 mg/cu.m) although deficiencies in most of these studies preclude
confirming this finding unequivocally. Descriptions of a number of these
studies follow. The preponderence of the literature showing CNS effects and
the well-known proclivity for solvents to affect CNS processes in humans leave
little doubt that the brain is a principal target organ for toluene toxicity
in humans.
In cases of inhalation abuse of toluene, Rosenberg et al. (1988)
demonstrated diffuse cerebral, cerebellar, and brainstem atrophy in 3 of 11
toluene abusers who also had neurological abnormalities. Filley et al. (1990)
were able to correlate neuropsychological impairment with the degree of white
matter abnormality (p<0.01). Cerebellar and cortical functions were
classified as impaired in 15/24 individuals who had abused toluene daily (425
+/- 366 mg/day) for extended periods (6.3 +/- 3.9 years) (Fornazzari et al.,
1983). In a limited case study, Metrick and Brenner (1982) demonstrated
brainstem atrophy through computerized tomographic scans and abnormal
brainstem auditory-evoked potentials in 2/2 chronic toluene abusers (12-16
years of admitted, continuous abuse). These studies confirm the occurrence of
severe CNS damage in response to highly abusive concentrations of toluene.
Several studies that have investigated the occurrence of neurotoxicity at
lesser concentrations, such as occupational situations, have not demonstrated
significant neurological or other effects. Hanninen et al. (1987) performed a
battery of 11 psychological tests on 43 printing workers who had been
occupationally exposed to approximately 117 ppm (441 mg/cu.m) toluene for an
average of 22 years and found only mildly adverse effects in 2/11 tests. The
control and exposed cohorts in this study were, however, mismatched in several
areas, most notably alcohol use. Iregren (1982) examined the psychological
performance of 38 printers who had been occupationally exposed to 50-150 ppm
(188-565 mg/cu.m) toluene for an average of 16.3 years (range 3-32 years). No
effects were seen, although the cohorts in this study were apparently matched
only by age. In a cohort study, Cherry et al. (1985) attempted to better match
the control and exposed cohorts and considered alcohol use. Although no
differences between the cohorts were statistically significant, the exposed
workers performed worse than the nonexposed workers on 10/13 psychological
tests. The 52 workers in this study were not, however, rigorously matched, and
the concentrations listed in the study ranged up to greater than 500 ppm (1884
mg/cu.m). The cohorts in the study of Foo et al. (1990) were well matched for
a number of confounders, including alcohol use, and statistically significant
psychological effects were seen.
In the occupational study conducted by Yin et al. (1987), 94 solvent
workers (38 men and 56 women; average employment duration, 6.8 years) and 138
controls (48 men and 90 women) were examined for exposure using diffusion
dosimeters, subjective symptoms by questionnaire, hematology, and urinalysis.
Exposure concentration (7-hour mean TWA) in the workers was estimated at 42.8
ppm (161 mg/cu.m) toluene with a maximum measurement of 123 ppm (464 mg/cu.m).
Workers were co-exposed to 1.3 ppm benzene. No exposure-related effects were
noted in any of the biochemical tests examined. In considering the prevalence
of subjective symptoms (sore throat, headaches, and dizziness) workers were
subgrouped into low (6-39 ppm, n = 28) and high (40-123 ppm, n = 29)
categories. Although the prevalence of subjective symptoms was significantly
higher in the exposed workers compared with the control cohort (p<0.01), a
concentration-response relationship was not discernable among the groups. No
other treatment-related effects were reported. The study was limited because
the exposed and unexposed groups were not matched to control for confounding
effects (e.g., age, smoking, alcohol consumption, exposure duration). Based
on these results, exposure to an average of approximately 42.8 ppm toluene
produced no biochemical abnormalities, although neither respiratory irritation
nor psychological performance was directly evaluated in these workers.
In the occupational study by Lee et al. (1988), prevalence of subjective
symptoms was categorized with respect to exposure levels. The study
population (193 women and 65 controls) completed a questionnaire. The
exposures were reported as 8-hour TWAs, and workers were grouped in exposure
categories of nonexposed, 1-50 ppm, 51-100 ppm, 101-150 ppm, and more than 151
ppm (duration of exposures was not reported). A concentration-dependent
increase in prevalence was reported for 25/67 symptoms with increases in
complaints over controls occurring at around 100 ppm (348 mg/cu.m). Similar
to the Yin et al. study (1987) reported above, symptomatology included
headaches, sore throats, and dizziness. Although an effect level in humans of
around 100 ppm is indicated by this study, no objective measures of toxicity
were examined.
A number of acute human studies have focused on toluene effects. In
general, these studies corroborate subjective CNS effects such as headaches
and dizziness reported in other longer-term occupational studies (Yin et al.,
1987; Lee et al., 1988) and also document irritation effects. The study of
Echeverria et al. (1989) correlates the occurrence of these subjective effects
with substantial neurological symptoms.
Forty-two college students (21 female and 21 male) were exposed to 0, 74
ppm (279 mg/cu.m), or 151 ppm (569 mg/cu.m) toluene for 7 hours over 3 days
(Echeverria et al., 1989). This exposure sequence was repeated for a total of
42 exposures over a 3-month period. The odor of toluene was masked. A battery
of performance tests was administered to each participant prior to starting
the exposures and again at 4 and 7 hours during the exposure; the initial test
served as a control for those tests performed during the exposure. A 5-10%
decrement in performance was considered significant if consistent with a
linear trend. Test results for visual perception differed from control values
for both exposure levels. Results of a manual dexterity test differed from
control values at the higher but not the lower exposure level. Psychomotor
test results were unaffected by toluene exposure. Subjective symptomatology
increased with exposure with increasing numbers of complaints of eye
irritation, headache, and somnolence. A NOAEL of 74 ppm (279 mg/cu.m) is
indicated for these results. The duration-adjusted value is 122 mg/cu.m for
these acute effects.
Andersen et al. (1983) exposed 16 subjects (average age of 24 years) to 0,
10, 40, or 100 ppm (0, 38, 151, or 377 mg/cu.m) toluene for 6 hours on each of
4 consecutive days. Individuals were tested for nasal mucous flow, lung
function, subjective response, and psychometric performance. At 100 ppm,
irritation was experienced in the eyes and nose, but no effect on nasal mucous
flow or lung function was observed. The subjects frequently reported
headaches, dizziness, and a feeling of intoxication. These effects were not
reported by the 10- or 40-ppm exposure groups. No effects were seen in
performance tests. This study indicates an effect level of 100 ppm, and a
NOAEL of 40 ppm (151 mg/cu.m).
The acute study by Baelum et al. (1990) evaluated 32 males and 39 females
exposed to 0 or 100 ppm (0 or 377 mg/cu.m), or to varying exposures of 50-300
ppm (188-1131 mg/cu.m) (TWA = 102 ppm), for 7 hours. Volunteers exercised on
an ergometer cycle for 3 periods of 15 minutes each during the exposure. No
significant differences were found in the performances between the exposed and
control groups in a battery of tests for performance, visual attention, and
reaction times. Exposed subjects reported an increase over nonexposed
subjects (p<0.1) in nose and lower respiratory irritation, feelings of
intoxication, dizziness, increased coughing, and headaches. Differences were
not noted between the group exposed to a constant level (100 ppm) and the
group exposed to the same TWA, but with peaks of up to 300 ppm.
Baelum et al. (1985) investigated the effects of a 6.5-hour toluene
exposure to 43 printers with a long-term occupational exposure to a mixture of
solvents including toluene and 43 controls with no history of exposure to
solvents or other chemicals. The duration of employment for the workers
ranged from 9-25 years. Each individual was exposed only once to either 0 or
100 ppm (0 or 377 mg/cu.m) toluene during a 6.5-hour exposure period, preceded
by a 1-hour acclimatization period. These subjects were then subgrouped into
printers exposed to toluene (n = 20), printers exposed to air (n = 23),
controls exposed to toluene (n = 21), and controls exposed to air (n = 22).
All subjects carried out a battery of tests for psychometric performance,
visual perception, and vigilance evaluation. Both printers and controls
complained of nasal and eye irritation, unacceptable air quality, and
unacceptable odor level during the toluene exposure. Signs of neurotoxicity,
including moderate fatigue, sleepiness, headaches, and a feeling of
intoxication, were likewise similarly reported for both groups. A significant
decrease in performance was found for the pegboard visual motor function test
in the exposed printers, but not in the controls exposed to 100 ppm toluene.
A decrease in psychometric performance, primarily in visual perception and
accuracy, was observed in toluene-exposed individuals. Acute exposure to
toluene resulted in a lower performance in 4/10 tests conducted, 3 of these 4
evaluated visual perception. The most profound difference between subjects
exposed to 100 ppm toluene and those exposed to clean air was observed in the
color discrimination test; this difference was seen in both exposed vs.
nonexposed printers and exposed vs. nonexposed controls. This study indicates
that little tolerance develops to the irritative and central effects in humans
exposed to toluene and that 100 ppm (377 mg/cu.m) is the effect level for
these symptoms.
Von Oettingen et al. (1942) exposed 3 humans to 100 or 200 ppm (377 or 754
mg/cu.m) toluene vapors for 8 hours. At 200 ppm, the subjects experienced
muscular weakness, confusion, impaired coordination, and dilated pupils, with
after-effects including fatigue, general confusion, and moderate insomnia. In
1 subject exposed to 100 ppm toluene, moderate fatigue, sleepiness, and
headaches were reported.
Hepatotoxicity has also been examined as a toxicologic endpoint of toluene
exposure in humans. Fornazzari et al. (1983) described moderate elevation of
serum AP levels in 13/24 (and SGOT in 7/24) toluene abusers upon admission to
a clinic. These elevated levels were normal after 2 weeks of solvent
abstinence, although the accompanying CNS effects were only minimally
improved. In a cross-sectional study of 181 printing workers in which toluene
exposures were less than 200 mg/cu.m, no adverse effects were apparent as
judged from serum liver enzymes (Boewer et al., 1988). In another cross-
sectional occupational study conducted by Guzelian et al. (1988) that involved
289 printing factory employees, 8 workers were found who had an increase
described as "marked" in the ratio of ALT/AST enzyme serum activity. Biopsies
revealed mild pericentral fatty livers in each of the eight cases. Based on
environmental data (probably area monitors) the levels of toluene to which
these workers were exposed was less than 200 mg/cu.m., 2-8 hours/day.
Fischer 344 rats (120/sex/group) inhaled 0, 30, 100, or 300 ppm (0, 113,
377, or 1130 mg/cu.m, respectively) toluene (99.9% purity), 6 hours/day, 5
days/week (duration-adjusted to 0, 20, 67, or 202 mg/cu.m, respectively) for
106 weeks (CIIT, 1980; Gibson and Hardisty, 1983). Vapor, generated by
bubbling clean air through toluene, was passed through the air supply duct and
mixed with air by turbulent flow to produce the desired concentration.
Hematology, blood chemistry, and urinalysis were conducted in all groups at 6
(5/sex), 17 (5/sex), 18 (10-20/sex), and 24 months (10/sex). Histopathology
was evaluated only in the control and 300-ppm groups at 6 (5/sex), 12 (5/sex),
and 18 months (20/sex). At 24 months, histopathological examinations were
conducted in organs of all surviving animals, including the respiratory system
and sections through the nasal turbinates (number not indicated). No
treatment-related non-neoplastic effects were observed in the exposed animals.
Although the male rats exposed to 300 ppm had a significant increase in body
weight compared to controls, no concentration-response was evident. At the
end of the exposure period, the female rats exposed to 100 or 300 ppm
exhibited a slight but significant reduction in hematocrit; an increase in the
mean corpuscular hemoglobin concentration was also noted but only in the
females exposed to 300 ppm. The highest concentration examined in this study,
300 ppm, is designated as a NOAEL for toxicity remote from the respiratory
tract in rats. CIIT (1980) reported that the technical and raw data were not
audited by their quality assurance group during the study period, although
CIIT did conduct a quality assessment procedure to review the data. The
available pathology reports containing these data indicate that at least the
lower respiratory tract was examined. Communication with the testing sponsor
has provided information indicating that only one section was examined from
the nasal cavity of these test animals. It is not clear whether this single
section would have been sufficient to elucidate the areas of lesions noted in
the NTP (1990) study. Consequently, the designation of the 300-ppm exposure
level as a NOAEL for respiratory lesions (see NTP,1990) is problematic.
Fischer 344/N rats (10/sex/group) were exposed to toluene vapors at 0,
100, 625, 1250, 2500, and 3000 ppm (0, 377, 2355, 4711, 9422, and 11,307
mg/cu.m, respectively) 6.5 hours/day, 5 days/week (duration-adjusted to 0, 73,
455, 911, 1823, and 2187 mg/cu.m, respectively) for 15 weeks (NTP, 1990).
Organ weights were measured and histological examinations were performed only
on controls, 2500- and 3000-ppm groups, and animals that died before the end
of the study. Eight of 10 males exposed to 3000 ppm died, all during the 2nd
exposure week. No females died at any exposure level. Compared to the
controls, final body weights were 15 and 25% lower in the males and 15 and 14%
lower in the females of the 2500- and 3000-ppm groups, respectively. There
was a concentration-related increase in the relative liver weight, significant
at 1250, 2500, and 3000 ppm in males and at 2500 and 3000 ppm in females. The
relative weights of the heart, lung, kidney, and right testis were also
significantly elevated in the 2500- and 3000-ppm animals compared to those of
the controls, although no histopathology was observed in any exposure group.
Toxic effects noted in a concurrently conducted gavage study (urinary bladder
hemorrhages in the two highest exposure groups) were not noted in this
subchronic inhalation study. A LOAEL of 2500 ppm [LOAEL(HEC) = 1823 mg/cu.m]
was determined for the decrease in body weight gain in both males and females,
and the NOAEL for this effect was 1250 ppm [NOAEL(HEC) = 911 mg/cu.m].
Toluene has been suspected to cause congenital defects in infants born to
mothers who were exposed to or who abused toluene during pregnancy. In a case
report study, Hersh et al. (1985) describes clinical and morphometric
characteristics common to 3 children whose mothers had abused toluene (but
apparently not alcohol or any other substance) for a period of 4-5 years
including during their pregnancies with the affected children. Clinical
findings common to these three children included microcephaly, CNS
dysfunction, attention deficits, and developmental delay/mental deficiency.
Phenotypic similarities included a small midface, deep-set eyes, micrognathia
(smallness of the jaws), and blunting of the fingertips. A retrospective
cohort study was conducted by McDonald et al. (1987) who examined the history
of exposure to chemicals of 301 women who had recently given birth to an
infant with an important congenital defect. An identical number of women
(referents) who had given birth to normal children were matched with respect
to age, employment (hours/week), date of delivery, and educational level. In
initial matched-pair analysis, chemical exposure was higher in the cases than
in the referents (63 cases:47 referents) due to excess cardiac and
miscellaneous defects. In further analysis by chemical categories, only
exposure to aromatic solvents showed a clear excess of defects, mostly in the
urinary tract. Details of these cases (n = 19) showed that toluene was
identified as the solvent in 11 of these cases.
Hudak and Ungvary (1978) exposed three groups of pregnant CFY rats to
toluene during different periods of gestation and for different durations of
exposure. Two of the groups had their own control group exposed to air only
and matched for period and daily duration. The first of these (n = 19) was
exposed to 1500 mg/cu.m for 24 hours/day during gestational days 9 to 14. Two
dams died during these exposures. No details on the deaths are given but no
other maternal toxicity was observed. Fetotoxicity was also in evidence as
sternebral alterations (6% vs. 1% in controls), extra ribs (22% vs. 0% in
controls), and the presence of fetuses with missing tails (2/213, none observed
in 315 controls) were recorded. Under these exposure conditions, 1500 mg/cu.m
is a LOAEL for fetotoxicity and a frank effect level (FEL) for maternal
toxicity. The second group (n = 14) received this same concentration
continuously but on days 1-8 of gestation. Five dams died under these exposure
conditions although toxicity parameters of the surviving dams were identical
with the controls from the first group (gestational days 9-14). Slight
hydrocephaly was noted in 4 fetuses (all from the same litter), and 17% growth
retardation was noted vs. 7% in the controls. Thus these exposure conditions
are a FEL for maternal toxicity and a LOAEL for fetotoxicity. A third group
was exposed to 1000 mg/cu.m for 8 hours/day from the 1st to the 21st day of
gestation. No maternal deaths or toxicity occurred. Minor skeletal
retardation was present in the exposed fetuses at a higher incidence rate (25%)
than in concurrent controls (0%). These results indicate that 1000 mg/cu.m is
a LOAEL for developmental effects under these exposure conditions. This
concentration is also a NOAEL for maternal effects. These workers also exposed
groups of pregnant CFLP mice (n = 11-15) to either air or 1500 or 500 mg/cu.m
toluene continuously during days 6-13 of pregnancy. All mice exposed to the
high concentration died within 24 hours of the beginning of exposure. No dams
died in the lower exposure group. In this group, the average fetal weight
decreased to 0.96 g from the average control weight of 1.07 g, and the
percentage of weight-retarded fetuses (less than 0.9 g) increased to 27.6% from
6.5% in the controls. No difference in incidence of skeletal malformations or
anomalies was noted between these and control fetuses. For mice, 1500 mg/cu.m
is an FEL and 500 mg/cu.m is a mild LOAEL. Since duration adjustment is not
performed for developmental effects, this concentration is also the LOAEL(HEC).
B6C3F1 mice (60/sex/group) were exposed to 0, 120, 600, or 1200 ppm (0,
452, 2261, or 4523 mg/cu.m, respectively) toluene 6.5 hours/day, 5 days/week
(duration-adjusted to 0, 87, 47, and 875 mg/cu.m, respectively) for 2 years
(NTP, 1990). Mean body weights were not significantly different among groups
and no treatment-related clinical signs were observed. Deaths (moribund and
natural) occurred in all exposure groups but were not related to exposure and
were not greater than the control rates. An excess incidence of non-
neoplastic inflammatory lesions of the urinary and genital system was observed
in all the groups of male mice. At the 15-month interim sacrifice, minimal
hyperplasia in the bronchial epithelium was observed in 4/10 females exposed
to 1200 ppm. At the end of the study, there was a concentration-dependent
increase in the incidence of splenic pigmentation in the exposed males (9/60,
11/60, and 18/59 at 120, 600, and 1200 ppm, respectively) compared to controls
(4/60). In the females, the incidence was 37/50, 33/50, 34/49, and 28/47 at
0, 120, 600, and 1200 ppm, respectively. The occurrence of endometrial
hyperplasia was present in 14% of the animals exposed to the highest
concentration but only in 4% in the low-exposure groups and controls. No
differences were noted between the exposed and control mice of either sex in
the incidence of degeneration of either the olfactory or respiratory
epithelium. No other non-neoplastic lesions were observed in exposed mice.
As no adverse effects were noted in this study, the highest concentration,
1200 ppm was designated as a NOAEL in mice for this chronic study [NOAEL(HEC)
= 875 mg/cu.m].
Sprague-Dawley rats (15/sex/group) were exposed to cumulative mean
exposures of 0, 100, or 1481 ppm (0, 377, or 5653 mg/cu.m) toluene vapors, 6
hours/day, 5 days/week (duration-adjusted to 0, 67, and 1009 mg/cu.m,
respectively) for 26 weeks (API, 1981). On weeks 9, 18, and 27,
neurohistopathological examinations were conducted in 3-5 rats/sex/group.
Hematology, clinical chemistry, and urinalysis parameters were evaluated after
13 and 26 weeks of exposure. Body weights were measured weekly. No
significant treatment-related effects were reported. Therefore, a NOAEL of
1481 ppm [NOAEL(HEC) = 1009 mg/cu.m] toluene was determined for systemic
effects in rats. The study was limited because there were no other
neurohistopathological examinations or organ weight measurements conducted on
the animals.
Inhalation exposure to toluene has been shown to result in irreversible
high-frequency hearing loss in rats. Pryor et al. (1984) exposed young male
Fischer 344 rats to a variety of exposure concentrations and durations.
Hearing loss was evaluated by a behavioral technique (avoidance response
elicited to an auditory signal) or brainstem auditory-evoked responses
(elicited by tone pips of differing loudness and frequency and detected by
subdural scalp electrodes). Hearing loss, as measured by both techniques, was
observed after as few as 2 weeks exposure to 1000 ppm toluene for 14
hours/day. Lower concentrations of 700 ppm for 14 hours/day were without
effect after 16 weeks of exposure. Intermittent exposure to 3000 ppm for 30
minutes/hour for 8 hours/day caused hearing loss within 2 weeks, whereas a
similar exposure schedule for only 4 hours/day was without effect after 9
weeks. These data define a NOAEL for hearing loss in rats of 700 ppm
[NOAEL(HEC) = 2638 mg/cu.m]. The duration-adjusted HEC (assumed 5 days/week)
would be 14/24 hours x 5/7 days = 1100 mg/cu.m. Although these results
clearly document hearing loss in young adult rats, their direct significance
to humans remains unclear. Among chronic toluene abusers there is only a
single report of adverse effects on hearing; Metrick and Brenner (1982)
claimed that the abnormal auditory-evoked potentials recorded in two chronic
toluene abusers was evidence of brainstem abnormalities.
Pregnant Wistar rats and hamsters (group size not indicated) inhaled 0 or
800 mg/cu.m toluene vapors 6 hours/day on gestational days 14-20 (rats) or
gestational days 6 to 11 (hamsters) (DaSilva et al., 1990). In the exposed
rats, there was a significant (p<0.05) increase in the number of litters with
one or more low birth weight pups (less than 4.9 g), from 10% in the controls
to 54% in the exposed dams. A decrease (p<0.05) in the number of live pups at
birth was also noted in the litters of exposed dams. No evaluation of
malformations or anomalies was performed. The neurobehavioral development of
the offspring of the exposed rats was assessed using tests of spontaneous
alternation, rim escape, and avoidance responses. The only effect noted in the
rats, a shortened first trial latency in choosing one side of a maze, was
minimal and its significance unclear. No comparable reproductive deficits
occurred in the exposed hamsters. The only effect noted in the neurobehavioral
tests of the hamster offspring was an equivocal effect in rota-rod performance.
No neurobehavioral effect levels were designated from this study, although it
appears that the rat developmental processes are more sensitive than those of
the hamster, exhibiting adverse effects at 800 mg/cu.m.
Ungvary and Tatrai (1985) exposed New Zealand rabbits (8-10/group) to 0,
500, or 1000 mg/cu.m toluene, 24 hours/day, on gestational days 7-20, and CFLP
mice (15 females/group) to 0, 500, 1000, or 1500 mg/cu.m toluene, also
continuously, on gestational days 6-15. The control groups consisted of 115
mice and 60 rabbits. All the female mice exposed to 1500 mg/cu.m died. In
the mice exposed to 1000 mg/cu.m, there was an increase in fetuses with
retarded weight (29%, level of retardation not indicated) and in fetuses with
skeletal retardation (12%) compared to 7% and 5%, respectively, in the
controls, which did not differ from the animals exposed to 500 mg/cu.m. Of
the 8 pregnant rabbits exposed to 1000 mg/cu.m, 2 died, 4 had spontaneous
abortions, and the remaining 2 had total litter resorption. No deaths
occurred in the 10 rabbits exposed to 500 mg/cu.m but 1/10 rabbits had a
spontaneous abortion (as compared to 0/60 reported for the controls). A
NOAEL(HEC) of 500 mg/cu.m toluene was determined for reproductive effects in
mice. For rabbits, the 500 mg/cu.m concentration is designated as a LOAEL.
These results indicate that pregnant mice may be a sensitive population to the
effects of toluene.
Pregnant Charles River CD-1 mice (15-16 females/group) inhaled filtered
air or 200 or 400 ppm (754 and 1508 mg/cu.m) toluene 7 hours/day on
gestational days 7-16 (Courtney et al., 1986). The relative liver weight in
the exposed dams was reported to be significantly lower in the two exposed
groups compared to the controls, although no data were presented. A
statistically significant increase in lactate dehydrogenase activity in the
brain of the dams exposed to 400 ppm was also reported. The exposed pregnant
mice did not exhibit any significant differences in the number of implantation
sites, number of live fetuses, fetal deaths, or fetal body weight compared to
the control values. A statistically significant increase over controls in the
incidence (both per litter and per fetus) of enlarged renal pelves was noted
in dams exposed to 200 ppm but not 400 ppm. A statistically significant
alteration from controls in the rib profile (percentage of fetuses with 1 or 2
additional/fewer ribs) was reported for fetuses from dams exposed to 400 ppm
but not 200 ppm. The toxicological significance of this finding is not clear.
As no clearly significant toxicological effects were observed, the highest
concentration used, 400 ppm [NOAEL(HEC) = 1508 mg/cu.m] is designated as a
NOAEL for reproductive and developmental effects in mice.
A 2-generation inhalation reproductive study was conducted in CD rats (10-
40 males, 20-80 females/group) (API, 1985). Animals were exposed by whole-
body inhalation to toluene at 0, 100, 500, or 2000 ppm (0, 377, 1885, or 7538
mg/cu.m, respectively) 6 hours/day, 7 days/week for 80 days and a 15-day
mating period. The mated females were then exposed to the same concentrations
during days 1-20 of gestation and days 5-20 of lactation. After weaning, the
pups in this generation (F1) were exposed 80 times and then randomly mated
with members of the same exposure group (2 females/1 male) to produce the
second generation (F2). Mean male body weights were slightly reduced (maximum
of 10%) in the first 2 weeks of the exposure in the animals exposed to 500 and
2000 ppm, although the size of the reduction was not related to exposure. No
differences were observed in male or female fertility indices, length of
gestation, mean numbers of viable and nonviable pups at birth, or pup survival
indices during lactation. No abnormal histopathology was noted in organs
examined. A significant decrease (p<0.05) in weight relative to controls was
observed in the first generation offspring. The decrease was maintained
throughout the lactation period in the pups from dams exposed to the highest
exposure and in those from the ancillary group in which females exposed to the
2000 ppm concentration were mated with males having no exposure. No data were
available in the report about the F2 generation. Based on the effects on the
pups of the first generation (F1), a LOAEL of 2000 ppm [LOAEL(HEC) = 7538
mg/cu.m] is designated, the NOAEL being 500 ppm [NOAEL(HEC) = 1885 mg/cu.m].
__I.B.5.
Confidence in the Inhalation RfC
Study -- Medium
Database -- Medium
RfC -- Medium
The study of Foo et al. (1990) indicates adverse neurological effects of
toluene in a small worker population. These effects are consistent with more
severe CNS effects occurring at abusive concentrations of toluene and could
not have been confounded by alcohol as the control and exposed populations did
not use alcohol. However, the paucity of exposure information and
identification of only a LOAEL is not sufficient to warrant a higher
confidence than medium for this study.
Other studies indicate that irritation may occur at around the same
concentration, 100 ppm (Baelum et al., 1985; Echeverria et al., 1989). In
regard to this effect, the NTP (1990) rat chronic inhalation study was well
conducted, established the rat as the most sensitive species, examined an
adequate number of animals, and performed histopathology on all major organs,
including the brain and the respiratory tract. The sensitive endpoint was the
concentration-dependent degeneration of the nasal epithelium characterized by
the erosion of the olfactory epithelium and degeneration of the respiratory
epithelium in male rats. The NTP study is also given medium confidence,
however, as it did not establish a NOAEL.
Although this database has a complement of chronic laboratory animal
studies, long-term data in humans are not available for either the
neurotoxicity or irritation endpoints. The reproductive/developmental studies
in three species were not comprehensive in endpoint evaluation but do identify
the rabbit as the most sensitive species. The database is thus given a
medium confidence rating. A medium confidence rating for the RfC follows.
__I.B.6.
EPA Documentation and Review of the Inhalation RfC
Source Document -- This assessment is not presented in any existing U.S. EPA
document.
Other EPA Documentation -- U.S. EPA, 1984, 1985
Agency Work Group Review -- 04/21/1988, 05/26/1988, 02/16/1989, 03/21/1989, 05/18/1989,
08/15/1991, 12/11/1991
Verification Date -- 05/18/1989, 12/11/1991
__I.B.7.
EPA Contacts (Inhalation RfC)
Please contact the IRIS Hotline for all
questions concerning this assessment or IRIS, in general, at (202)566-1676
(phone), (202)566-1749 (FAX) or hotline.iris@epa.gov
(internet address).
Back to top
_II.
Carcinogenicity Assessment for Lifetime Exposure
Substance Name -- Toluene
CASRN -- 108-88-3
Last Revised -- 02/01/1994
Section II provides information on three aspects of
the carcinogenic assessment for the substance in question; the weight-of-evidence
judgment of the likelihood that the substance is a human carcinogen, and
quantitative estimates of risk from oral exposure and from inhalation
exposure. The quantitative risk estimates are presented in three ways.
The slope factor is the result of application of a low-dose extrapolation
procedure and is presented as the risk per (mg/kg)/day. The unit risk
is the quantitative estimate in terms of either risk per ug/L drinking
water or risk per ug/cu.m air breathed. The third form in which risk is
presented is a drinking water or air concentration providing cancer risks
of 1 in 10,000, 1 in 100,000 or 1 in 1,000,000. The rationale and methods
used to develop the carcinogenicity information in IRIS are described
in The Risk Assessment Guidelines of 1986 (EPA/600/8-87/045) and in the
IRIS Background Document. IRIS summaries developed since the publication
of EPA's more recent Proposed Guidelines for Carcinogen Risk Assessment
also utilize those Guidelines where indicated (Federal Register 61(79):17960-18011,
April 23, 1996). Users are referred to Section I of this IRIS file for
information on long-term toxic effects other than carcinogenicity.
_II.A.
Evidence for Human Carcinogenicity
__II.A.1.
Weight-of-Evidence Characterization
Classification -- D; not classified
Basis -- No human data and inadequate animal data. Toluene did not produce
positive results in the majority of genotoxic assays.
__II.A.2.
Human Carcinogenicity Data
None.
__II.A.3.
Animal Carcinogenicity Data
A chronic (106-week) bioassay of toluene in F344 rats of both sexes
reported no carcinogenic responses (CIIT, 1980). A total of 960 rats were
exposed by inhalation for 6 hours/day, 5 days/week to toluene at 0, 30, 100,
or 300 ppm. Groups of 20/sex/dose were sacrificed at 18 months. Gross and
microscopic examination of tissues and organs identified no increase in
neoplastic tissue or tumor masses among treated rats when compared with
controls. The study is considered inadequate because the highest dose
administered was well below the MTD for toluene and because of the high
incidence of lesions and pathological changes in the control animals.
Several studies have examined the carcinogenicity of toluene following
repeated dermal applications. Toluene (dose not reported) applied to shaved
interscapular skin of 54 male mice (strains A/He, C3HeB, SWR) throughout their
lifetime (3 times weekly) produced no carcinogen1c response (Poel, 1963). One
drop of toluene (about 6 mL) applied to the dorsal skin of 20 random-bred
albino mice twice weekly for 50 weeks caused no skin papillomas or carcinomas
after a 1-year latency period was allowed (Coombs et al., 1973). No increase
in the incidence of skin or systemic tumors was demonstrated in male or female
mice of three strains (CF, C3H, or CBaH) when toluene was applied to the back
of 25 mice of each sex of each strain at 0.05-0.1 mL/mouse, twice weekly for
56 weeks (Doak et al., 1976). One skin papilloma and a single skin carcinoma
were reported among a group of 30 mice treated dermally with one drop of 0.2%
(w/v) solution toluene twice weekly, administered from droppers delivering 16-
20 uL per drop for 72 weeks (Lijinsky and Garcia, 1972). It is not reported
whether evaporation of toluene from the skin was prevented during these
studies.
__II.A.4.
Supporting Data for Carcinogenicity
Toluene was found to be nonmutagenic in reverse mutation assays with S.
typhimurium (Mortelmans and Riccio, 1980; Nestmann et al., 1980; Bos et al.,
1981; Litton Bionetics, Inc., 1981; Snow et al., 1981) and E. coli (Mortelmans
and Riccio, 1980), with and without metabolic activation. Toluene did not
induce mitotic gene conversion (Litton Bionetics, Inc., 1981; Mortelmans and
Riccio, 1980) or mitotic crossing over (Mortelmans and Riccio, 1980) in S.
cerevisiae. Although Litton Bionetics, Inc. (1981) reported that toluene did
not cause increased chromosomal aberrations in bone marrow cells, several
Russian studies (Dobrokhotov, 1972; Lyapkalo, 1973) report toluene as
effective in causing chromosal damage in bone marrow cells of rats. There was
no evidence of chromosomal aberrations in blood lymphocytes of workers exposed
to toluene only (Maki-Paakkanen et al., 1980; Forni et al., 1971), although a
slight increase was noted in workers exposed to toluene and benzene (Forni et
al., 1971; Funes-Craviota et al., 1977). This finding is supported by studies
of cultured human lymphocytes exposed to toluene in vitro; no elevation of
chromosomal aberrations or sister chromatid exchanges was observed (Gerner-
Smidt and Friedrich, 1978).
Back to top
_II.B.
Quantitative Estimate of Carcinogenic Risk from Oral
Exposure
Not available.
Back to top
_II.C.
Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure
Not available.
Back to top
_II.D.
EPA Documentation, Review, and Contacts (Carcinogenicity Assessment)
__II.D.1.
EPA Documentation
Source Document -- U.S. EPA, 1987
The values in the 1987 Drinking Water Criteria Document for Toluene have
received peer and administrative review.
__II.D.2.
EPA Review (Carcinogenicity Assessment)
Agency Work Group Review -- 09/15/1987
Verification Date -- 09/15/1987
__II.D.3.
EPA Contacts (Carcinogenicity Assessment)
Please contact the IRIS Hotline for all
questions concerning this assessment or IRIS, in general, at (202)566-1676
(phone), (202)566-1749 (FAX) or hotline.iris@epa.gov
(internet address).
Back to top
_VI.
Bibliography
Substance Name -- Toluene
CASRN -- 108-88-3
Last Revised -- 08/01/1992
_VI.A.
Oral RfD References
CIIT (Chemical Industry Institute of Technology). 1980. A 24-month
inhalation toxicology study in Fischer-344 rats exposed to atmospheric
toluene. CIIT, Research Triangle Park, NC.
Kostas, J. and J. Hotchin. 1981. Behavioral effects of low-level perinatal
exposure to toluene in mice. Neurobehav. Toxicol. Teratol. 3: 467-469.
Nawrot, P.S. and R.E. Staples. 1979. Embryo-fetal toxicity and
teratogenicity of benzene and toluene in the mouse. Teratology. 19: 41A
(abstr.)
NTP (National Toxicology Program). 1989. Toxicology and carcinogenesis
studies of toluene (CAS No. 108-88-3) in F344/N rats and B5C3F1 mice
(inhalation studies). Technical Report Series No. 371. Research Triangle
Park, NC.
Wolf, M.A., V.K. Rowe, D.D. McCollister, R.L. Hollingsworth and F. Oyen.
1956. Toxicological studies of certain alkylated benzenes and benzene. Arch.
Ind. Health. 14: 387-398.
Back to top
_VI.B.
Inhalation RfC References
ACGIH (American Conference of Governmental Industrial Hygienists). 1991.
Notice of intended changes - toluene, trimethylamine, and vinyl acetate.
Appl. Occup. Environ. Hyg. 6(11): 966-977.
Andersen, I., G.R. Lundqvist, L. Molhave et al. 1983. Human response to
controlled levels of toluene in six-hour exposures. Scand. J. Work Environ.
Health. 9: 405-418.
API (American Petroleum Institute). 1981. 26-Week inhalation toxicity study
of toluene in the rat. Conducted by Bio/dynamics Inc. and Institute of
Neurotoxicity, Albert Einstein College of Medicine for API, Washington, DC.
API (American Petroleum Institute). 1985. Two-generation inhalation
reproduction/fertility study on a petroleum-derived hydrocarbon. Doc. ID FYI-
AX-0284-0294 IN. Microfiche No. 0294.
Baelum, J., I. Andersen, G.R. Lundqvist et al. 1985. Response of solvent-
exposed printers and unexposed controls to six-hour toluene exposure. Scand.
J. Work Environ. Health. 11: 271-280.
Baelum, J., G. Lundqvist, L. Molhave and N.T. Andersen. 1990. Human response
to varying concentrations of toluene. Int. Arch. Occup. Environ. Health.
62(1): 65-71.
Boewer, C., G. Enderlein, U. Wollgast, S. Nawka, H. Palowski, and R. Bleiber.
1988. Epidemiological study on the hepatotoxicity of occupational toluene
exposure. Int. Arch. Occup. Environ. Health. 60: 181-186.
Cherry, N., H. Hutchins, T. Pace and H.A. Waldron. 1985. Neurobehavioral
effects of repeated occupational exposure to toluene and paint solvents. Br.
J. Ind. Med. 42(5): 291-300.
CIIT (Chemical Industry Institute of Toxicology). 1980. A twenty-four month
inhalation toxicology study in Fischer-344 rats exposed to atmospheric
toluene. Conducted by Industrial Bio-Test Laboratories, Inc., Decatur, IL, and
Experimental Pathology Laboratories, Inc., Raleigh, NC, for CIIT, Research
Triangle Park, NC. October 15, 1980.
Courtney, K.D., J.E. Andrews, J. Springer et al. 1986. A perinatal study of
toluene in CD-1 mice. Fund. Appl. Toxicol. 6: 145-154.
DaSilva, V.A., L.R. Malheiros and F.M.R. Bueno. 1990. Effects of toluene
exposure during gestation on neurobehavioral development of rats and hamsters.
Brazil J. Med. Biol. Res. 23: 533-537.
Echeverria, D., L. Fine, G. Langolf, A. Schork and C. Sampio. 1989. Acute
neurobehavioral effects of toluene. Br. J. Ind. Med. 46(7): 483-495.
Filley, C.M., R.K. Heaton and N.L. Rosenberg. 1990. White matter dementia in
chronic toluene abuse. Neurology. 40: 532-534.
Foo, S.C., J. Jeyaratnam and D. Koh. 1990. Chronic neurobehavioral effects
of toluene. Br. J. Ind. Med. 47(7): 480-484.
Fornazzari, L., D.A. Wilkinson, B.M. Kapur and P.L. Carlen. 1983.
Cerebellar, cortical and functional impairment in toluene abusers. Acta
Neurol. Scand. 67: 319-329.
Gibson, J.E. and J.F. Hardisty. 1983. Chronic toxicity and oncogenicity
bioassay of inhaled toluene in Fischer-344 rats. Fund. Appl. Toxicol. 3:
315-319.
Guzelian, P., S. Mills and H.J. Fallon. 1988. Liver structure and function
in print workers exposed to toluene. J. Occup. Med. 30(10): 791-796.
Hanninen, H., M. Antti-Poika and P. Savolainen. 1987. Psychological
performance, toluene exposure and alcohol consumption in rotogravure printers.
Int. Arch. Occup. Environ. Health. 59(5): 475-483.
Hersh, J.H., P.E. Podruch, G. Rogers and B. Weisskopf. 1985. Toluene
embryopathy. J. Pediatr. 106: 922-927.
Hudak, A. and G. Ungvary. 1978. Embryotoxic effects of benzene and its
methyl derivatives: Toluene, xylene. Toxicology. 11: 55-63.
Iregren, A. 1982. Effects on psychological test performance of workers
exposed to a single solvent (toluene) - a comparison with effects of exposure
to a mixture of organic solvents. Neurobehav. Toxicol. Teratol. 4(6): 695-
701.
Lee, B., S. Lee, K. Lee et al. 1988. Dose-dependent increase in subjective
symptom prevalence among toluene-exposed workers. Ind. Health. 26(1): 11-23.
McDonald, J.C., J. Lavoie, R. Cote and A.D. McDonald. 1987. Chemical
exposures at work in early pregnancy and congenital defect: A case-referent
study. Br. J. Ind. Medicine. 44: 527-533.
Metrick, S.A. and R.P. Brenner. 1982. Abnormal brainstem auditory evoked
potentials in chronic paint sniffers. Ann. Neurol. 12: 553-556.
NTP (National Toxicology Program). 1990. Toxicology and carcinogenesis
studies of toluene (CAS No. 108-88-3) in F344/N rats and B6C3F1 mice
(inhalation studies). NTP-TR-371.
Pryor, G.T., C.S. Rebert, J. Dickinson and E.M. Feeney. 1984. Factors
affecting toluene-induced ototoxicity in rats. Neurobehav. Toxicol. Teratol.
6: 223-238.
Rosenberg, N.L., M.C. Spitz, C.M. Filley, K.A. Davis, and H.H. Schaumburg.
1988. Central nervous system effects of chronic toluene abuse - clinical,
brainstem evoked response and magnetic resonance imaging studies.
Neurotoxicol. Teratol. 10: 489-495.
Ungvary, G. and E. Tatrai. 1985. On the embryotoxic effects of benzene and
its alkyl derivatives in mice, rats, and rabbits. Arch. Toxicol. Suppl. 8:
425-430.
U.S. EPA. 1984. Health Effects Assessment for Toluene. Prepared by the
Office of Health and Environmental Assessment, Environmental Criteria and
Assessment Office, Cincinnati, OH, for the Office of Emergency and Remedial
Response, Washington, DC. EPA-600/X-84-188.
U.S. EPA. 1985. Drinking Water Criteria Document for Toluene. Prepared by
the Office of Health and Environmental Assessment, Environmental Criteria and
Assessment Office, Cincinnati, OH, for the Office of Drinking Water,
Washington, DC. EPA/540/1-86-033.
Von Oettingen, W.F., P.A. Neal, D.D. Donahue et al. 1942. The toxicity and
potential dangers of toluene, with special reference to its maximal
permissible concentration. U.S. Public Health Service, Public Health Bulletin
No. 279: 50.
Yin, S., G. Li, Y. Hu et al. 1987. Symptoms and signs of workers exposed to
benzene, toluene or the combination. Ind. Health. 25(3): 113-130.
Back to top
_VI.C.
Carcinogenicity Assessment References
Bos, R.P., R.M.E. Brouns, R. van Doorn, J.L.G. Theuws and P.Th. Henderson.
1981. Non-mutagenicity of toluene, o-, m- and p-xylene, o-methylbenzylalcohol
and o-methylbenzylsulfate in the Ames assay. Mutat. Res. 88(3): 273-279.
CIIT (Chemical Industry Institute of Toxicology). 1980. A twenty-four-month
inhalation toxicology study in Fischer-344 rats exposed to atmospheric
toluene. Executive Summary and Data Tables, October 15. CIIT, Research
Triangle Park, NC.
Coombs, M.M., T.S. Bhatt and C.J. Croft. 1973. Correlation between
carcinogenicity and chemical structure in cyclopenta(a)phenanthrenes. Cancer
Res. 33(4): 832-837.
Doak, S.M.A., B.J.E. Simpson, P.F. Hunt and D.E. Stevenson. 1976. The
carcinogenic response in mice to the topical application of propane sultone to
the skin. Toxicology. 6: 139-154.
Dobrokhotov, V.B. 1972. The mutagenic influence of benzene and toluene under
experimental conditions. Gig. Sanit. 37: 36-39. (Rus.) (Evaluation based
on an English translation provided by the U.S. EPA.)
Forni, A., E. Pacifico and A. Limonta. 1971. Chromosome studies in workers
exposed to benzene or toluene or both. Arch. Environ. Health. 22(3):
373-378.
Funes-Craviota, F., B. Kolmodin-hedman, J. Lindsten, et al. 1977. Chromosome
aberrations and sister-chromatid exchange in workers in chemical laboratories
and a rotoprinting factory and in children of women laboratory workers.
Lancet. 2: 322-325.
Gerner-Smidt, P. and U. Friedrich. 1978. The mutagenic effect of benzene,
toluene and xylene studied by the SCE technique. Mutat. Res. 58(2-3):
313-316.
Lijinsky, W. and H. Garcia. 1972. Skin carcinogenesis tests of hydrogenated
derivatives of anthanthrene and other polynuclear hydrocarbons. Z.
Krebsforsch. Klin. Onkol. 77: 226-230.
Litton Bionetics, Inc. 1981. Mutagenicity Evaluation of Toluene Mouse
Dominant Lethal Assay. Final Report. Submitted to the American Petroleum
Institute, Washington, DC in January, 1981. LBI Project No. 21141-05. Litton
Bionetics, Inc., Kansington, MD. p. 58.
Lyapkalo, A.A. 1973. Genetic activity of benzene and toluene. Gig. Tr.
Prof. Zabol. 17(3): 24-28. (Rus.) (Evaluation based on an English
translation provided by the U.S. EPA.)
Maki-Paakkanen, J., K. Husgafvel-Pursiainen, P.L. Kalliomaki, J. Tuominen and
M. Sorsa. 1980. Toluene-exposed workers and chromosome aberrations. J.
Toxicol. Environ. Health. 6: 775-781.
Mortelmans, K.E. and E.S. Riccio. 1980. In vitro microbiological
genotoxicity assays of toluene. Prepared by SRI International, Menlo Park,
CA, under Contract No. 68-02-2947 for the U.S. EPA, Research Triangle Park,
NC. p. 25.
Nestmann, E.R., E.G.H. Lee, T.I. Matula, G.R. Douglas and J.C. Mueller.
1980. Mutagenicity of constituents identified in pulp and paper mill
effluents using the Salmonella/mammalian-microsome assay. Mutat. Res. 79:
203-212.
Poel, W.E. 1963. Skin as a test site for the bioassay of carcinogens and
carcinogen precursors. Natl. Cancer Inst. Monogr. 10: 611-625.
Snow, L., P. MacNair and B.C. Casto. 1981. Mutagenesis testing of toluene
in Salmonella strains TA100 and TA98. Report prepared for the U.S. EPA by
Northrup Services, Inc., Research Triangle park, NC.
U.S. EPA. 1987. Drinking Water Criteria Document for Toluene. Prepared by
the Office of Health and Environmental Assessment, Environmental Criteria and
Assessment Office, Cincinnati, OH for the Office of Drinking Water,
Washington, DC.
Back to top
_VII.
Revision History
Substance Name -- Toluene
CASRN -- 108-88-3
03/01/1988 |
I.A.4. |
Text revised |
09/07/1988 |
II. |
Carcinogen summary
on-line |
02/01/1989 |
II.D.3. |
Secondary contact's
phone number corrected |
07/01/1989 |
I.B. |
Inhalation RfD now
under review |
03/01/1990 |
VI. |
Bibliography on-line |
04/01/1990 |
VI.C. |
Combs et al., 1973
citation corrected |
06/01/1990 |
IV.A.1. |
Area code for EPA contact
corrected |
06/01/1990 |
IV.F.1. |
EPA contact changed |
07/01/1990 |
I.A. |
Withdrawn; new RfD
verified (in preparation) |
07/01/1990 |
VI.A. |
Oral RfD references
withdrawn |
08/01/1990 |
I.A. |
Oral RfD summary replaced;
RfD changed |
08/01/1990 |
II. |
Text edited |
08/01/1990 |
VI.A. |
Oral RfD references
revised |
09/01/1990 |
III.A. |
Health Advisory on-line |
09/01/1990 |
VI.D. |
Health Advisory references
added |
08/01/1991 |
VI.C. |
Litton Bionetics,
Inc., 1981 reference title clarified |
01/01/1992 |
IV. |
Regulatory actions
updated |
04/01/1992 |
IV.A.1. |
CAA regulatory action
withdrawn |
08/01/1992 |
I.B. |
Inhalation RfC on-line |
08/01/1992 |
VI.B. |
Inhalation references
on-line |
02/01/1994 |
II.D.3. |
Secondary contact's
phone number changed |
04/01/1994 |
I.A.7. |
Primary contact changed |
04/01/1997 |
III., IV., V. |
Drinking Water Health
Advisories, EPA Regulatory Actions, and Supplementary Data were removed
from IRIS on or before April 1997. IRIS users were directed to the
appropriate EPA Program Offices for this information. |
02/22/2001 |
I., II. |
This chemical is being
reassessed under the IRIS Program. |
Back to top
_VIII.
Synonyms
Substance Name -- Toluene
CASRN -- 108-88-3
Last Revised -- 01/31/1987
108-88-3
ANTISAL 1a
BENZENE, METHYL
METHACIDE
METHYL-BENZENE
METHYLBENZOL
NCI-C07272
PHENYL-METHANE
RCRA WASTE NUMBER U220
TOLUEEN
TOLUEN
Toluene
TOLUOL
TOLUOLO
TOLU-SOL
UN 1294
Back to top
|
|